CorMedix Inc. (CRMD) vs Fulgent Genetics, Inc. (FLGT)

A side-by-side comparison of CorMedix Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRMD vs FLGT

growth of $100 · dividends reinvested · last 10y
CRMD -48.3% (-6.4%/yr)FLGT +130.1% (+8.7%/yr)FLGT compounded faster over this window
05001k2kStart $10020182020202220242026$52$230
CRMD FLGT

CRMD vs FLGT: by the numbers

  • •FLGT is the larger company ($588M vs $566M market cap).
  • •CRMD is profitable (40.49% net margin) while FLGT runs a net loss (-26.05%).
  • •CRMD grew revenue faster over the past five years (352.03% vs -18.66% CAGR).

Metrics side by side

Valuation

MetricCRMDFLGT
P/E ratio3.39N/A
Forward P/E14.59N/A
P/S ratio1.231.82
P/B ratio1.230.59
EV / EBITDA1.80N/A
FCF yield44.18%N/A

Profitability

MetricCRMDFLGT
Gross margin82.78%35.58%
Operating margin46.95%-28.23%
Net margin40.49%-26.05%
ROE40.62%-8.42%
ROIC27.87%-11.80%

Growth (annualized)

MetricCRMDFLGT
Revenue CAGR (5Y)352.03%-18.66%
Total return CAGR (5Y)9.70%-22.38%

Frequently asked

Which has grown faster, CRMD or FLGT?
Over the past five years, CRMD grew revenue faster — CRMD at a 352.03% CAGR versus FLGT at -18.66%.
Is CRMD or FLGT more profitable?
CRMD runs the higher net margin — CRMD at 40.49% versus FLGT at -26.05%.
How have CRMD and FLGT total returns compared?
Over the past 10 years, CRMD delivered -7.74% and FLGT delivered 8.90% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.